This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
ILD, hospital admission 2, with pulmonary infections
DOID EFO MESH SNOMED Endpoint Browser
ILD_HOSPITAL_PULM_INFECT
interstitial lung disease: A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of pulmonary alveoli that extends to the interstitium and beyond leading to diffuse pulmonary fibrosis. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.
Endpoint definition
↥
FinnGen phenotype data
429209 individuals
Apply sex-specific rule None
429209
Check conditions
PULM_INFECTIONS
134244
Check pre-conditions, main-only, mode, registry filters None
0 out of 7 registries used, show all original rules.
0
Check minimum number of events None
0
Remove individuals based on genotype QC
2865
ILD_HOSPITAL_PULM_INFECT
Control definitions
Control conditions
not PULM_INFECTIONS
Extra metadata
First used in FinnGen datafreeze
DF2
No data for upset plot.
No data for upset table.
Similar endpoints
↥List of similar endpoints to
ILD, hospital admission 2, with pulmonary infections
based on the number of shared cases.
Broader endpoints:
- ILD, hospital admissions
- Interstitial lung disease
- Other interstitial pulmonary diseases
- Interstitial lung disease endpoints
- Respiratory diseases principally affecting the interstitium, IBD co-morbidites
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2865 | 1116 | 1749 |
| Unadjusted prevalence (%) | 0.70 | 0.48 | 0.96 |
| Mean age at first event (years) | 65.76 | 63.26 | 67.36 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: ILD_HOSPITAL_PULM_INFECT – ILD, hospital admission 2, with pulmonary infections
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after ILD, hospital admission 2, with pulmonary infections
↥Endpoint not on priority list, no data to show.